These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors. Brand K; Arnold W; Bartels T; Lieber A; Kay MA; Strauss M; Dörken B Cancer Gene Ther; 1997; 4(1):9-16. PubMed ID: 9012446 [TBL] [Abstract][Full Text] [Related]
44. Adenovirus vector-mediated herpes simplex virus-thymidine kinase gene/ganciclovir system exhibits anti-tumor effects in an orthotopic hepatocellular carcinoma model. Zhu R; Chen D; Lin D; Lu F; Yin J; Li N Pharmazie; 2014 Jul; 69(7):547-52. PubMed ID: 25073402 [TBL] [Abstract][Full Text] [Related]
45. Targeted expression of herpes simplex virus thymidine kinase in adenovirus-infected cells reduces virus titers upon treatment with ganciclovir in vitro. Ibrišimović M; Nagl U; Kneidinger D; Rauch M; Lion T; Klein R J Gene Med; 2012 Jan; 14(1):3-19. PubMed ID: 22190534 [TBL] [Abstract][Full Text] [Related]
46. Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase gene. Carrió M; Romagosa A; Mercadé E; Mazo A; Nadal M; Gómez-Foix AM; Fillat C Gene Ther; 1999 Apr; 6(4):547-53. PubMed ID: 10476214 [TBL] [Abstract][Full Text] [Related]
47. Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approach. Brand K; Löser P; Arnold W; Bartels T; Strauss M Gene Ther; 1998 Oct; 5(10):1363-71. PubMed ID: 9930342 [TBL] [Abstract][Full Text] [Related]
49. Liposomal encapsulation of ganciclovir enhances the efficacy of herpes simplex virus type 1 thymidine kinase suicide gene therapy against hepatic tumors in rats. Engelmann C; Panis Y; Bolard J; Diquet B; Fabre M; Nagy H; Soubrane O; Houssin D; Klatzmann D Hum Gene Ther; 1999 Jun; 10(9):1545-51. PubMed ID: 10395379 [TBL] [Abstract][Full Text] [Related]
50. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model. Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166 [TBL] [Abstract][Full Text] [Related]
51. Golgi membrane protein GP73 modified-liposome mediates the antitumor effect of survivin promoter-driven HSVtk in hepatocellular carcinoma. Liu C; Wen C; Wang X; Wei Y; Xu C; Mu X; Zhang L; Wang X; Tian J; Ma P; Meng F; Zhang Q; Zhao N; Yu B; Gong T; Guo R; Wang H; Xie J; Sun G; Li G; Zhang H; Qin Q; Xu J; Dong X; Wang L Exp Cell Res; 2019 Oct; 383(1):111496. PubMed ID: 31306654 [TBL] [Abstract][Full Text] [Related]
52. Heat-directed suicide gene therapy mediated by heat shock protein promoter for gastric cancer. Isomoto H; Ohtsuru A; Braiden V; Iwamatsu M; Miki F; Kawashita Y; Mizuta Y; Kaneda Y; Kohno S; Yamashita S Oncol Rep; 2006 Mar; 15(3):629-35. PubMed ID: 16465423 [TBL] [Abstract][Full Text] [Related]
53. [Construction and identification of recombinant vectors carrying herpes simplex virus thymidine kinase genes expressed in vascular endothelial cells]. Liu XP; Li BJ; Zhang C Ai Zheng; 2006 Feb; 25(2):179-84. PubMed ID: 16480582 [TBL] [Abstract][Full Text] [Related]
54. Adenovirus-mediated suicide-gene therapy in an orthotopic murine bladder tumor model. Cheon J; Moon DG; Cho HY; Park HS; Kim JJ; Gardner TA; Kao C Int J Urol; 2002 May; 9(5):261-7. PubMed ID: 12060439 [TBL] [Abstract][Full Text] [Related]
56. Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan. Wildner O; Blaese RM; Morris JC Hum Gene Ther; 1999 Nov; 10(16):2679-87. PubMed ID: 10566896 [TBL] [Abstract][Full Text] [Related]
57. Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs. Wildner O; Hoffmann D; Jogler C; Uberla K Cancer Gene Ther; 2003 Oct; 10(10):791-802. PubMed ID: 14502232 [TBL] [Abstract][Full Text] [Related]
58. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model. Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258 [TBL] [Abstract][Full Text] [Related]
59. [Adenovirus-mediated double suicide gene therapy for experimental bladder carcinoma]. Tan WL; Xie Y; Wu YD; Zhu WH; Zheng SB Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):594-7. PubMed ID: 16762858 [TBL] [Abstract][Full Text] [Related]
60. Potent anti-tumor activity of telomerase-dependent and HSV-TK armed oncolytic adenovirus for non-small cell lung cancer in vitro and in vivo. Zhang JF; Wei F; Wang HP; Li HM; Qiu W; Ren PK; Chen XF; Huang Q J Exp Clin Cancer Res; 2010 May; 29(1):52. PubMed ID: 20487549 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]